For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Formerly known as juvenile diabetes, type 1 diabetes can develop at any age. Learn how it progresses differently among children and adults and what screening options exist.

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading and help Philly news thrive, unlock this exclusive offer for unlimited ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...

In today's Morning Rounds newsletter: a failed long Covid drug may get another shot, the benefits of even a little activity ...

For patients with type 2 diabetes, GLP-1 RAs are associated with an increased risk for GERD compared with SGLT-2 inhibitors.

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

No increased risk of thrombotic events identified despite rise in erythrocytosis among sodium-glucose cotransporter 2 ...

Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key ...

In a new clinical practice guideline, recommendations are presented for pregnancy care in individuals with preexisting diabetes mellitus.